top of page

Search

Get to know Allucent -- a full-service, global provider of comprehensive drug development solutions for small and mid-sized biopharmas.

blonca9
Jul 9, 2024
1 min read

They're on a mission to help bring new therapies to light. Here's how they can help you.

Learn more: Allucent.com

Recent Posts

Lexeo Therapeutics' CEO Nolan Townsend highlights recent FA cardiomyopathy data and the path ahead in that indication. Plus, the latest on PKP2 ACM, and more

Lexeo Therapeutics' CEO Nolan Townsend highlights recent FA cardiomyopathy data and the path ahead in that indication. Plus, the latest on PKP2 ACM, and more

Metsera's CEO Whit Bernard on the obesity space, including GLP-1s, amylin analogs, and how the company is also developing both as oral peptides

Metsera's CEO Whit Bernard on the obesity space, including GLP-1s, amylin analogs, and how the company is also developing both as oral peptides

Allucent: Alex MacDonald, VP, Global Head of Model-Informed Drug Development at Allucent, discusses how his team supports biotech companies throughout the drug development journey

Allucent: Alex MacDonald, VP, Global Head of Model-Informed Drug Development at Allucent, discusses how his team supports biotech companies throughout the drug development journey

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page